Israel: "Groundbreaking scientific development” toward a potential treatment for COVID-19
Subrata Mukhopadhyay
Director of MFG Automation & Controls at KOVALUS Separation Solutions (Previously Koch Engineered Solutions / Koch separation solutions)
...But the process may take several months.
The Israel Institute for Biological Research (IIBR) said on Tuesday that it completed a “groundbreaking scientific development” toward a potential treatment for COVID-19 based on an antibody that neutralizes SARS-CoV2, the coronavirus that causes the disease.
“This is an important milestone, which will be followed by a series of complex tests and a process of regulatory approvals,” the ministry said in a statement, adding that the process could take several months given “the nature of this breakthrough.”
The development has three key parameters, according to the IIBR: first, the antibody is monoclonal (lab-made identical immune cells that are all clones of a unique parent cell), and contains a low proportion of harmful proteins; second, the institute has “demonstrated the ability of the antibody to neutralize the coronavirus”; and third, the antibody was specifically tested on SARS CoV2.
“Based on comprehensive scientific publications from around the globe, it appears that the IIBR is the first institution to achieve a scientific breakthrough that meets all three of the aforementioned parameters simultaneously,” the ministry said on Tuesday.
For more info. pls. visit: https://nocamels.com/2020/05/israeli-bio-defense-lab-antibody-neutralizes-coronavirus/